Skip to content
2000
Volume 4, Issue 6
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

The identification and characterization of the inducible form of cyclooxygenases (COX-2) stimulated the investigations to develop efficient, non-steroidal anti-inflammatory drugs (NSAIDs) with reduced side effects (essentially gastro-intestinal toxicity) compared to classical NSAIDs. This review focuses on the chemical and pharmacological properties (pre-clinical data) of marketed COX-2 inhibitors.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/1389557043403693
2004-08-01
2025-11-03
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/1389557043403693
Loading

  • Article Type:
    Review Article
Keyword(s): cox-2 inhibitors; cox-2 selectivity; pre-clinical data
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test